Skip to content
For research use only. Not for human or veterinary use. Not a drug, food, or dietary supplement.
Class

Short bioregulator peptides

Short bioregulator peptides, often called Khavinson peptides, are synthetic di-, tri- and tetrapeptides from a St Petersburg research programme, many designed from the amino-acid composition of organ extracts. Their developers propose an epigenetic mechanism: that the peptides enter cells, reach the nucleus and bind DNA or histones to change which genes are expressed. Most of the supporting work is in cultured cells, tissue explants and computational docking, largely from the originating group. No receptor or defined molecular target has been identified for most of them.

How the members differ

  • Each is framed as organ-directed, matching the tissue its template extract came from, such as Cardiogen for heart and Pancragen for pancreas; one explant study reported organ-matched growth stimulation.
  • Vilon and Epithalon have whole-animal lifespan or circadian reports from the originating group, whereas Cartalax, Chonluten and Testagen have only cell or cell-free data.
  • Pancragen and Vesugen each have one small, uncontrolled human report, and Thymalin, a thymus extract rather than a synthetic peptide, has non-randomised COVID-19 reports.
  • Cortagen was repeatedly the weakest or inactive member when compared head-to-head with its sister peptides.

Compounds in this group

Compare Pancragen, Thymalin, Epithalon side by side

For research use only. Not for human or veterinary use. Not a drug, food, or dietary supplement. Mechanism descriptions summarize published research and are not claims of effect in people.